| Description: | A Phase 2, 2 part trial to evaluate the safety and efficacy of galeterone in castration resistant prostate cancer (CRPC) patients. |
|---|
| Link: | http://clinicaltrials.gov/ct2/show/NCT01709734 |
|---|---|
| Site: | Walter Reed National Military Medical Center |
| Principle Investigator: | David McLeod, MD |